Page last updated: 2024-09-02

valerates and clofilium

valerates has been researched along with clofilium in 1 studies

Compound Research Comparison

Studies
(valerates)
Trials
(valerates)
Recent Studies (post-2010)
(valerates)
Studies
(clofilium)
Trials
(clofilium)
Recent Studies (post-2010) (clofilium)
2,251294457140121

Protein Interaction Comparison

ProteinTaxonomyvalerates (IC50)clofilium (IC50)
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.0813

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bringmann, A; Chen, J; Färber, K; Grosse, J; Illes, P; Krügel, U; Linnertz, R; Lipp, S; Pannicke, T; Reichenbach, A; Schöneberg, T; Schulz, A; Wiedemann, P; Wurm, A; Zahn, D1

Other Studies

1 other study(ies) available for valerates and clofilium

ArticleYear
Endogenous purinergic signaling is required for osmotic volume regulation of retinal glial cells.
    Journal of neurochemistry, 2010, Volume: 112, Issue:5

    Topics: 5'-Nucleotidase; Adenine; Adenosine Diphosphate; Animals; Barium Compounds; Calcium; Cell Size; Chlorides; Cyclic AMP; Drug Combinations; Enzyme Inhibitors; In Vitro Techniques; Inositol 1,4,5-Trisphosphate Receptors; Mice; Mice, Knockout; Neuroglia; Neurons; Osmolar Concentration; Osmosis; Potassium Channel Blockers; Purinergic Agonists; Purinergic Antagonists; Pyrimidine Nucleotides; Quaternary Ammonium Compounds; Receptors, Purinergic; Retina; Signal Transduction; Thionucleotides; Time Factors; Valerates; Xanthines

2010